Bioxytran Inc Sustainability Reports
Bioxytran, Inc. is a clinical-stage biotechnology company that develops carbohydrate-based drugs and platform technologies to treat viral infections, hypoxia, and degenerative diseases. The company specializes in creating galectin inhibitors and oxygen-carrying small molecules designed to treat conditions like ischemia and COVID-19.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300Q3J615PTZIU425
FIGI: BBG001T5DRY3
1 reports from 2023 to 2023
